SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001193125-03-083251
Filing Date
2003-11-18
Accepted
2003-11-18 16:39:48
Documents
15

Document Format Files

Seq Description Document Type Size
1 RULE 425 FILING d425.htm 425 30374
3 GRAPHIC g12679slide_03.jpg GRAPHIC 126849
4 GRAPHIC g12679slide_04.jpg GRAPHIC 512108
5 GRAPHIC g12679slide_05.jpg GRAPHIC 385214
6 GRAPHIC g12679slide_06.jpg GRAPHIC 316510
7 GRAPHIC g12679slide_07.jpg GRAPHIC 214222
8 GRAPHIC g12679slide_08.jpg GRAPHIC 328902
9 GRAPHIC g12679slide_09.jpg GRAPHIC 377046
10 GRAPHIC g12679slide_10.jpg GRAPHIC 282624
11 GRAPHIC g12679slide_11.jpg GRAPHIC 284290
12 GRAPHIC g12679slide_12.jpg GRAPHIC 322536
13 GRAPHIC g12679slide_13.jpg GRAPHIC 187570
14 GRAPHIC g12679slide_14.jpg GRAPHIC 329217
15 GRAPHIC g12679slide_15.jpg GRAPHIC 235756
16 GRAPHIC g12679slide_16.jpg GRAPHIC 126849
  Complete submission text file 0001193125-03-083251.txt   4063709
Mailing Address 100 BEAVER STREET WALTHAM MA 02453
Business Address 1OO BEAVER ST WALTHAM MA 02453 7813982300
GENOME THERAPEUTICS CORP (Filed by) CIK: 0000356830 (see all company filings)

IRS No.: 042297484 | State of Incorp.: MA | Fiscal Year End: 0831
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 7300 SHORELINE COURT SOUTH SAN FRANCISCO CA 94080
Business Address 7300 SHORELINE COURT SOUTH SAN FRANCISCO CA 940080 650-837-1800
GENESOFT PHARMACEUTICALS INC (Subject) CIK: 0001206042 (see all company filings)

IRS No.: 770466785 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 132-02264 | Film No.: 031010862